Regen BioPharma Inc (RGBP)

[Schuller]

This is not the IR firm I heard about. There is additional funding ongoing to fund Hema but It's not Hema they're interested in . Hema is just another means to get to their main program NR2F6.

So I expect more dilution but as dilution goes it will eventually create value for all investors. IMO this will be a much happier board in the not to far future.

Best regards!
Schuller